TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice (Q33343490)

26 July 2017

title

TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice (English)

1 reference

26 July 2017

0 references

Michael Walter

4

0 references

author name string

Stefanie Frank

1

1 reference

26 July 2017

Guido J Burbach

2

1 reference

26 July 2017

Michael Bonin

3

1 reference

26 July 2017

Wolfgang Streit

5

1 reference

26 July 2017

Ingo Bechmann

6

1 reference

26 July 2017

Thomas Deller

7

1 reference

26 July 2017

publication date

1 October 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

56

1 reference

26 July 2017

issue

13

1 reference

26 July 2017

page(s)

1438-1447

1 reference

Pattern recognition by TREM-2: binding of anionic ligands

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

Association of microglia with amyloid plaques in brains of APP23 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

Cutting Edge: TREM-2 Attenuates Macrophage Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Inflammation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Failed central nervous system regeneration: a downside of immune privilege?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

What is the blood-brain barrier (not)?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Immunological aspects of microglia: relevance to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Nuclei and subnuclei gene expression profiling in mammalian brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Evolution of neuronal changes in the course of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Quantification of layer-specific gene expression in the hippocampus: effective use of laser microdissection in combination with quantitative RT-PCR.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Laser microdissection reveals regional and cellular differences in GFAP mRNA upregulation following brain injury, axonal denervation, and amyloid plaque deposition

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Laser microdissection of immunolabeled astrocytes allows quantification of astrocytic gene expression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Vessel ultrastructure in APP23 transgenic mice after passive anti-Abeta immunotherapy and subsequent intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

TREMs in the immune system and beyond

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR -- how well do they correlate?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

ATP mediates rapid microglial response to local brain injury in vivo

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Neuroinflammation in Alzheimer's disease and prion disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Laser capture microdissection

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

What is immune privilege (not)?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Current concepts and future prospects for Alzheimer disease vaccines

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Immunohistochemical evidence for a macrophage scavenger receptor in Mato cells and reactive microglia of ischemia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Expression of leukocyte antigen CD34 by brain capillaries in Alzheimer's disease and neurologically normal subjects

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Single-Cell Microarray Analysis in Hippocampus CA1: Demonstration and Validation of Cellular Heterogeneity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Correlating function and gene expression of individual basal ganglia neurons.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Immunology of viral-vector-mediated gene transfer into the brain: an evolutionary and developmental perspective

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Gene expression profiles of laser-captured adjacent neuronal subtypes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Reproducibility of oligonucleotide arrays using small samples

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Microglia in degenerative neurological disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Microglia and the control of autoreactive T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Cerebral hemorrhage after passive anti-Abeta immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

The RIN: an RNA integrity number for assigning integrity values to RNA measurements

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

A beta peptide deposition in the brains of transgenic mice: evidence for a key event in Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Microglia and neuroprotection: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Microglial senescence: does the brain's immune system have an expiration date?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Microglia and neuroinflammation: a pathological perspective

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Transgenic animals in Alzheimer's disease research.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20710

7 January 2021

Identifiers

DOI

10.1002/GLIA.20710

1 reference

26 July 2017

1 reference